Novo-Nordisk A/S Newsroom

Erste Group Initiates Novo-Nordisk A/S(NVO.US) With Hold Rating

Moomoo NewsOct 28 08:32 ET

Amylyx Upgraded to Buy by BofA on Hypoglycemia Drug Potential

Seeking AlphaOct 23 13:29 ET

BMO Capital Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Cuts Target Price to $156

Moomoo NewsOct 17 10:31 ET

Novo Nordisk Analyst Ratings

BenzingaOct 17 09:57 ET

Novo Nordisk Analyst Ratings

BenzingaOct 10 11:19 ET

TD Cowen Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $155

Moomoo NewsOct 8 00:32 ET

BofA Securities Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating

Moomoo NewsOct 2 10:31 ET

Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn't a Problem. -- Barrons.com

Barron'sOct 2 09:48 ET

BMO Capital Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsSep 25 07:33 ET

BMO Capital Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsSep 20 20:32 ET

TD Cowen Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Announces Target Price $155

Moomoo NewsSep 20 20:32 ET

Novo Nordisk Analyst Ratings

BenzingaSep 20 10:04 ET

Cantor Fitzgerald Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsSep 20 08:31 ET

Novo Nordisk Analyst Ratings

BenzingaSep 16 12:23 ET

Cantor Fitzgerald Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsSep 11 16:32 ET

BMO Capital Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsSep 11 15:31 ET

Novo Nordisk Analyst Ratings

BenzingaAug 19 12:27 ET

BMO Capital Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsAug 13 07:33 ET

Don't Forget This Startup's Weight-Loss Pill, Analyst Says -- Barrons.com

Barron'sAug 12 16:09 ET

Why Eli Lilly Is a Buy After Earnings. The Stock Got an Upgrade. -- Barrons.com

Barron'sAug 12 14:21 ET